BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2881776)

  • 1. Somatostatin-14-like antigenic sites in fixed islet D-cells are unaltered by cysteamine: a quantitative electron microscopic immunocytochemical evaluation.
    Patel YC; Ravazzola M; Amherdt M; Orci L
    Endocrinology; 1987 Apr; 120(4):1663-7. PubMed ID: 2881776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteamine induces a loss of tissue somatostatin-28 when measured as somatostatin-28(15-28)-like immunoreactivity but not when assessed as somatostatin-28(1-14)-like immunoreactivity: evidence for the importance of the disulfide bond for cysteamine action.
    Patel YC; Pierzchala I
    Endocrinology; 1985 May; 116(5):1699-702. PubMed ID: 2859189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. Evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion.
    Patel YC; Pierzchala I; Amherdt M; Orci L
    J Clin Invest; 1985 Apr; 75(4):1249-55. PubMed ID: 2859301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors.
    Srikant CB; Patel YC
    Endocrinology; 1984 Sep; 115(3):990-5. PubMed ID: 6146517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid depletion of somatostatin in isolated mouse pancreatic islets after treatment with cysteamine.
    Petersson B; Hellerström C
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):227-31. PubMed ID: 2865862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteamine-induced reduction in tissue somatostatin immunoreactivity is associated with alterations in somatostatin mRNA.
    Papachristou DN; Liu JL; Patel YC
    Regul Pept; 1994 Jan; 49(3):237-47. PubMed ID: 7908140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural localization of somatostatin in pancreatic islets of the rat.
    Goldsmith PC; Rose JC; Arimura A; Ganong WF
    Endocrinology; 1975 Oct; 97(4):1061-4. PubMed ID: 1104349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cysteamine administration on somatostatin biosynthesis and levels in rat hypothalamus.
    Kwok RP; Cameron JL; Faller DV; Fernstrom JD
    Endocrinology; 1992 Dec; 131(6):2999-3009. PubMed ID: 1359964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential proliferation of somatostatin and glucagon cells in rat pancreatic islets submitted to various stimuli.
    Pons P; Aoki A
    Ann Anat; 1995 May; 177(3):221-7. PubMed ID: 7598219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of cysteamine on cognitive and locomotor behavior in rats: relationship to hippocampal glial pathology and somatostatin levels.
    Justino L; Welner SA; Tannenbaum GS; Schipper HM
    Brain Res; 1997 Jun; 761(1):127-34. PubMed ID: 9247075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms involved in the depleting effect of cysteamine on pancreatic somatostatin.
    Hashimoto N; Kanatsuka A; Makino H; Sakurada M; Yoshida S
    Horm Metab Res; 1987 Jan; 19(1):11-4. PubMed ID: 2881872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of cysteamine on thyrotropin and immunoreactive beta-endorphin secretion in the rat.
    Millard WJ; Sagar SM; Badger TM; Carr DB; Arnold MA; Spindel E; Kasting NW; Martin JB
    Endocrinology; 1983 Feb; 112(2):518-25. PubMed ID: 6184215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteamine-induced depletion of somatostatinergic systems alters potentials evoked from the rat visual cortex.
    Fontanesi G; Siciliano R; Porciatti V; Bagnoli P
    Vis Neurosci; 1996; 13(2):327-34. PubMed ID: 8737284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and subcellular immunolocalization of L-glutamate decarboxylase in rat pancreatic islets.
    Garry DJ; Appel NM; Garry MG; Sorenson RL
    J Histochem Cytochem; 1988 Jun; 36(6):573-80. PubMed ID: 2896676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of action of cysteamine in depleting prolactin immunoreactivity.
    Sagar SM; Millard WJ; Martin JB; Murchison SC
    Endocrinology; 1985 Aug; 117(2):591-600. PubMed ID: 3926458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cysteamine on the hypothalamic-pituitary axis in the rat.
    McComb DJ; Cairns PD; Kovacs K; Szabo S
    Fed Proc; 1985 Jun; 44(9):2551-5. PubMed ID: 2860017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography.
    Amherdt M; Patel YC; Orci L
    J Clin Invest; 1987 Nov; 80(5):1455-8. PubMed ID: 2890658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteamine can induce duodenal ulceration in rats without depletion of immunoreactive somatostatin.
    Kapuscinski M; Shulkes A; Green M; Read D; MacLellan DG
    Regul Pept; 1991 Nov; 36(3):391-406. PubMed ID: 1687422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteamine-induced depletion of somatostatin in sheep: time course of depletion and changes in plasma metabolites, insulin, and growth hormone.
    McLeod KR; Harmon DL; Schillo KK; Mitchell GE
    J Anim Sci; 1995 Jan; 73(1):77-87. PubMed ID: 7601757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.